SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,031.31 -292.98
(-0.45%)

Nikkei 225

10,765.28 -116.62
(-1.07%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

48.95

1180.76

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.05

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	93.99	79.16	63.94	45.03	24.72	18.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	93.99	79.16	63.94	45.03	24.72	18.42
Other Income	6.84	2.91	2.81	1.58	0.72	0.81
Stock Adjustments	0.63	0.23	1.53	-1.30	0.44	0.71
Total Income	101.46	82.30	68.28	45.31	25.88	19.94
EXPENDITURE :
Raw Materials	41.29	35.27	29.21	20.14	12.71	12.21
Power & Fuel Cost	0.03	0.04	0.00	0.00	0.00	0.00
Employee Cost	8.54	9.17	6.51	5.47	3.42	2.95
Other Manufacturing Expenses	6.19	3.73	4.05	4.57	2.02	0.00
Selling & Administrative Expenses	8.37	4.89	4.45	2.98	2.70	0.00
Miscellaneous Expenses	0.48	0.31	0.25	0.02	0.17	3.17
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	64.90	53.41	44.47	33.18	21.02	18.33
Operating Profit	36.56	28.89	23.81	12.12	4.86	1.61
Interest	0.58	0.38	0.34	0.23	0.09	0.03
Gross Profit	35.98	28.51	23.47	11.89	4.77	1.58
Depreciation	2.75	1.87	1.12	0.48	0.15	0.18
Profit Before Tax	33.23	26.64	22.35	11.41	4.62	1.40
Tax	8.65	6.67	6.41	3.00	1.19	0.37
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.13	0.07	-0.68	-0.09	-0.01	-0.02
Reported Net Profit	24.71	19.90	16.62	8.50	3.43	1.06
Extraordinary Items	0.59	0.25	0.00	0.00	0.01	0.08
Adjusted Net Profit	24.12	19.65	16.62	8.50	3.42	0.98
Adjustment below Net Profit	-5.89	-4.44	0.00	-0.20	-0.99	0.00
P & L Balance brought forward	44.09	29.81	13.78	5.58	3.13	2.07
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.18	1.18	0.59	0.00	0.00	0.00
P & L Balance carried down	61.73	44.09	29.81	13.89	5.58	3.13
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	5.00	15.00	60.00	20.00	0.00	0.00
Dividend Per Share(Rs)	0.50	1.50	6.00	2.00	0.00	0.00
Earnings Per Share-Unit Curr	20.98	33.79	113.06	78.37	34.34	1059.50
Earnings Per Share(Adj)-Unit Curr	20.98	16.90	14.13	78.37	34.34	1059.50
Book Value-Unit Curr	276.49	411.24	1044.56	176.36	65.78	3143.70
Book Value(Adj)-Unit Curr	276.49	205.62	130.57	176.36	65.78	3143.70

73,852.90 -876.37 ( -1.17%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,031.31 -292.98 (-0.45%)

10,765.28 -116.62 (-1.07%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)